Receptors for prolactin (PRL-R) are expressed in normal leukocytes from rat and man. PRL signals through PRL-R associated Janus tyrosine kinase (Jak)-2 and signal transducers and activators of transcription (Stat). In addition, in human leukocytes PRL also activates the p38 MAP kinase pathway. PRL, at physiological concentrations, stimulates the expression of the interferon regulatory factor (IRF)-1 gene in rat spleen and bone marrow cells. In man, genes induced by PRL include several members of the `suppressors of cytokine signaling' (SOCS) family and inducible nitric oxide synthase (iNOS; in mononuclear cells and in granulocytes) and IRF-1 (in granulocytes). Thus, in normal leukocytes, PRL induces the expression of several genes relevant to innate and acquired immune responses.
Sex hormones, such as estrogen and PRL, have been implicated in the pathogenesis of murine and human SLE. Also defective signaling in leukocytes is a feature of the disease. What the origin is of aberrant signaling processes in SLE lymphocytes and how they relate to tolerance breakdown and immunopathology is still unknown. It is not unlikely that PRL is a player at some level. The exact contribution of PRL to immune responses in normal subjects and in SLE patients is not known. Further work should also indicate whether PRL might contribute to the onset or progression of the disease and assess the possible benefits of manipulating PRL concentrations in patients.
Horseman ND . Prolactin. Kluwer Academic: Boston, MA , 2001, p 412-412.
2.
Kooijman R , Hooghe-Peters EL , Hooghe R . Adv Immunol1996; 63: 377–454 .
3.
Hooghe-Peters EL , Hooghe R . Growth Hormone, Prolactin and IGF-I as Lymphohematopoietic Cytokines. RG Landes: Austin/Springer: New York , 1995, p 256-256.
4.
Dorshkind K , Horseman ND . The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic mpdels of hormone and hormone receptor defyciency . Endocr Rev2000; 21: 292–312 .
5.
Bole-Feysot C , Goffin V , Edery M , Binart N , Kelly PA . Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice . Endocr Rev1998; 19: 225–268 .
6.
Lahita RG . The role of sex hormones in systemic lupus erythematosus . Curr Opin Rheumatol1999; 11: 352–356 .
7.
Stevens A , Ray DW , Worthington J , Davis JRE . Polymorphisms of the human prolactin gene <Eth> implications for production of lymphocyte prolactin and systemic lupus erythematosus . Lupus2001; 10: 676–683 .
8.
Freeman ME , Kanyicska B , Lerant A , Nagy G . Prolactin: structure, function, and regulation of secretion . Physiol Rev2000; 80: 1523–1631 .
9.
Montgomery D.Prolactin production by immune cells . Lupus2001; 10: 665–675 .
10.
Walker AM . Unmodified and phosphorylated prolactin and gamma delta T cell development and function . Lupus2001; 10: 735–741 .
11.
D'Angelo G , Martini JF , Iiri T , Fantl WJ , Martial J , Weiner RI . 16K human prolactin inhibits vascular endothelial growth factor-induced activation of Ras in capillary endothelial cells . Mol Endocrinol1999; 13: 692–704 .
12.
Kline JB , Roehrs H , Clevenger CV . Functional characterization of the intermediate isoform of the human prolactin receptor . J Biol Chem1999; 274: 35461–35468 .
13.
Clevenger CV , Rycyzyn MA , Syed F , Kline JB . Prolactin receptor signal transduction. In: Horseman ND (ed.). Prolactin. Kluwer Academic: Boston, MA , 2001 p 355-355.
Bresson JL , Jeay S , Gagnerault MC et al. Growth hormone (GH) and prolactin receptors in human peripheral blood mononuclear cells: relation with age and GH-binding protein . Endocrinology1999; 140: 3203–3209 .
16.
Dogusan Z , Book ML , Verdood P , Yu-Lee Ly , Hooghe-Peters EL . Prolactin activates interferon regulatory factor-1 expression in normal lympho-hemopoietic cells . Eur Cytokine Networks2000; 11: 435–442 .
17.
Yasukawa H , Sasaki A , Yoshimura A . Negative regulation of cytokine signaling pathways . A Rev Immunol2000; 18: 143–164 .
18.
Dogusan Z , Hooghe-Peters EL , Berus D , Velkeniers B , Hooghe R . Expression of SOCS genes in normal and leukemic human leukocytes stimulated by prolactin, growth hormone and cytokines . J Neuroimmunol2000; 109: 34–39 .
19.
Cwikel S , Silvian-Drachsler I , Prolov L , Hooghe-Peters EL , Merchav S . Prolactin-induced expression of cytokine-inducible SH2 signaling inhibitors in human hematopoietic progenitors . Exp Hematol2001; 29: 937–942 .
20.
Clevenger CV , Freier DO , Kline JB . Prolactin receptor signal transduction in cells of the immune system . J Endocrinol1998; 157: 187–197 .
21.
Horseman ND , Yu-Lee Ly . Transcriptional regulation by the helix bundle peptide hormones: growth hormone, prolactin, and hematopoietic cytokines . Endocr Rev1994; 15: 627–649 .
22.
Krumenacker JS , Montgomery DW , Buckley DJ , Gout PW , Buckley AR . Prolactin receptor signaling: shared components with the T-cell antigen receptor in Nb2 lymphoma cells . Endocrine1998; 9: 313–320 .
23.
Schwertfeger KL , Hunter S , Heasley LE et al. Prolactin stimulates activation of c-jun N-terminal kinase (JNK) . Mol Endocrinol2000; 14: 1592–1602 .
24.
Selvaraj NG , Omi E , Gibori G , Rao MC . Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na/ 7 K/ 7 2Cl7cotransporter . Mol Endocrinol2000; 14: 2054–2065 .
25.
Olazabal I , Munoz J , Ogueta S , Obregon E , Garcia-Ruiz JP . Prolactin (PRL)-PRL receptor system increases cell proliferation involving JNK (c-Jun amino terminal kinase) and AP-1 activation: inhibition by glucocorticoids . Mol Endocrinol2000; 14: 564–575 .
26.
Villalba M , Zabala MT , Martinez-Serrano A , de la Colina R , Satrustegui J , Garcia-Ruiz JP . Prolactin increases cytosolic free calcium concentration in hepatocytes of lactating rats . Endocrinology1991; 129: 2857–2861 .
27.
Berlanga JJ , Gualillo O , Buteau H , Applanat M , Kelly PA , Edery M . Prolactin activates tyrosyl phosphorylation of insulin receptor substrate 1 and phosphatidylinositol-3-OH kinase . J Biol Chem1997; 272: 2050–2052 .
28.
Berlanga JJ , Fresno Vara JA , Martin-Perez J , Garcia-Ruiz JP . Prolactin receptor is associated with c-src kinase in rat liver . Mol Endocrinol1995; 9: 1461–1467 .
29.
Sorin B , Vacher AM , Djiane J , Vacher P . Role of protein kinases in the prolactin-induced intracellular calcium rise in Chinese hamster ovary cells expressing the prolactin receptor . J Neuroendocrinol2000; 12: 910–918 .
30.
Decker T.Transcription factor activity of STAT proteins: structural requirements and regulation by phosphorylation and interacting proteins . Cell Mol Life Sci1999; 55: 1505–1508 .
31.
Clayton AL , Rose S , Barratt MJ , Mahadevan LC . Phosphoacetylation of histone H3 on c-fos and c-jun-associated nucleosomes upon gene activation . EMBO J2000; 19: 3714–3726 .
32.
Bole-Feysot, C , Perret E , Roustan P , Bouchard B , Kelly PA . Analysis of prolactin-modulated gene expression profiles during the Nb2 cell cycle using differential screening techniques . Genome Biol2000; 1: research 0008.1–0008.15 .
33.
Ohteki T , Yoshida H , Matsuyama T , Duncan GS , Mak TW , Ohashi PS . The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1/ T cell receptor-alpha/beta/ (NK1/T) cells, natural killer cells, and intestinal intraepithelial T cells . J Exp Med1998; 187: 967–972 .
34.
McElligott DL , Phillips JA , Stillman CA , Koch RJ , Mosier DE , Hobbs MV . CD4/ T cells from IRF-1-deficient mice exhibit altered patterns of cytokine expression and cell subset homeostasis . J Immunol1997; 159: 4180–4186 .
35.
Taki S , Sato T , Ogasawara K et al. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1 . Immunity1997; 6: 673–679 .
36.
Meli R , Raso GM , Gualillo O , Pacilio M , Di Carlo R . Prolactin modulation of nitric oxide and TNF-alpha production by peripheral neutrophils in rats . Life Sci1997; 61: 1395–1403 .
37.
Raso GM , Meli R , Gualillo O , Pacilio M , Di Carlo R . Prolactin induction of nitric oxide synthase in rat C6 glioma cells . J Neurochem1999; 73: 2272–2277 .
38.
Di Carlo R , Meli R , Galdiero M , Nuzzo I , Bentivoglio C , Carratelli CR . Prolactin protection against lethal effects of Salmonella typhimurium . Life Sci1993; 53: 981–989 .
39.
Pezet A , Favre H , Kelly PA , Edery M . Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling . J Biol Chem1999; 274: 24497–24502 .
40.
Li S , Chen S , Xu X et al. Cytokine-induced Src homology 2 protein (CIS) promotes T cell receptor-mediated proliferation and prolongs survival of activated T cells . J Exp Med2000; 191: 985–994 .
41.
Helman D , Sandowski Y , Cohen Y et al. Cytokine-inducible SH2 protein (CIS3) and JAK2 binding protein (JAB) abolish prolactin receptor-mediated STAT5 signaling . FEBS Lett1998; 441: 287–291 .
42.
Dickensheets HL , Venkataraman C , Schindler U , Donnelly RP . Inter ferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression . Proc Natl Acad Sci USA1999; 96: 10800–10805 .
43.
Ito S , Ansari P , Sakatsume M et al. Interleukin-10 inhibits expression of both interferon alpha and interferon gamma-induced genes by suppressing tyrosine phosphorylation of STAT1 . Blood1999; 93: 1456–1463 .
44.
Magrangeas F , Boisteau O , Denis S , Jacques Y , Minvielle S . Negative cross-talk between interleukin-3 and interleukin-11 is mediated by suppressor of cytokine signalling-3 (SOCS-3) . Biochem J2001; 353: 223–230 .
45.
Matera L , Mori M , Geuna M , Buttiglieri S , Palestro G . Prolactin in autoimmunity and antitumor defence . J Neuroimmunol2000; 109: 47—55 .
46.
Fu YK , Arkins S , Li YM , Danzer R , Kelley KW . Reduction in superoxide anion secretion and bactericidal activity of neutrophils from aged rats: reversal by the combination of gamma interferon and growth hormone . Infect lmmunol1994; 62: 1—8 .
47.
Tsokos GC , Kammer GM . Molecular aberrations in human systemic lupus erythematosus . Mol Med Today2000; 6: 418–424 .
48.
Tsokos GC , Wong HK , Enyedy EJ , Nambiar MP . Immune cell signaling in lupus . Curr Opin Rheumatol2000; 12: 355–363 .
49.
Nambiar MP , Fisher CU , Enyedy EJ , Warke VG , Krishnan S , Tsokos GC . Heat stress downregulates TCR zeta chain expression in human T lymphocytes . J Cell Biochem2000; 79: 416–426 .
50.
Mishra N , Khan IU , Tsokos GC , Kammer GM . Association of deficient type II protein kinase A activity with aberrant nuclear translocation of the RII beta subunit in systemic lupus erythematosus T lymphocytes . J Immunol2000; 165: 2830–2840 .
51.
Wong HK , Kammer GM , Dennis G , Tsokos GC . Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression . J Immunol1999; 163: 1682–1689 .
52.
Laxminarayana D , Khan IU , Mishra N , Olorenshaw I , Tasken K , Kammer GM . Diminished levels of protein kinase A RI alpha and RI beta transcripts and proteins in systemic lupus erythematosus T lymphocytes . J Immunol1999; 162: 5639–5648 .
53.
Brundula V , Rivas LJ , Blasini AM et al. Diminished levels of T cell receptor zeta chains in peripheral blood T lymphocytes from patients with systemic lupus erythematosus . Arthritis Rheum1999; 42: 1908–1916 .
54.
Yi Y , McNerney M , Datta SK . Regulatory defects in cbl and mitogenactivated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells . J lmmunol2000; 165: 6627–6634 .
55.
Yellin MJ , Thienel U . T cells in the pathogenesis of systemic lupus erythematosus: potential roles of CD154–CD40 interactions and costimulatory molecules . Curr Rheumatol Rep2000; 2: 24–31 .
56.
Rapoport MJ , Mor A , Amit M et al. Decreased expression of the p21 ras stimulatory factor hSOS in PBMC from inactive SLE patients . Lupus1999; 8: 24–28 .
57.
Burgos P , Metz C , Bull P et al. Increased expression of c-rel, from the NF-kappaB/Rel family, in T cells from patients with systemic lupus erythematosus . J Rheumatol2000; 27: 116–127 .
58.
Gutierrez MA , Molina JF , Jara LJ et al. Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity . Lupus1995; 4: 348–352 .
59.
Thellin O , Coumans B , Devos S et al. Limited effects of placental and pituitary growth hormone on cytokine expression in vitro . Eur Cytokine Networks2000; 11: 452–455 .
60.
Cesario TC , Yousefi S , Carandang G , Sadati N , Le J , Vaziri N . Enhanced yields of gamma interferon in prolactin treated human peripheral blood mononuclear cells . Proc Soc Exp Biol Med1994; 205: 89–95 .
61.
Peeva E , Grimaldi C , Spatz L , Diamond B . Bromocriptine restores tolerance in estrogen-treated mice . J Clin Invest2000; 106: 1373–1379 .
62.
Glynne R , Ghandour G , Rayner J , Mack DH , Goodnow CC . B lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays . Immunol Rev2000; 176: 216–246 .
